Detroit Pistons forward Jalen Duren is pulling out of the 2026 slam dunk contest due to a knee injury he suffered last week, according to multiple reports. Duren, a first-time All-Star, exited ...

The 2026 Tiny Desk Contest, our annual search for the next great undiscovered artist, is now officially open for entries! From now until Feb. 9 at 11:59 p.m. ET, unsigned artists can submit on the ...

Myasthenia gravis (MG) or its treatments may lead to urinary symptoms. Studies suggest a link between overactive bladder symptoms and a common MG medication called pyridostigmine. Urinary symptoms in ...

The combination of Keytruda and Padcev is taking another major step toward securing its position as a leading therapy in the treatment of bladder cancer. The PD-1/antibody-drug conjugate pairing ...

OPEC+ left early-2025 production targets unchanged but approved a major new mechanism to reassess each member’s maximum sustainable production capacity. This new mechanism will be used to determine ...

TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, consistent release of chemotherapy proved far more effective than traditional ...

The FDA has approved Pfizer and Astellas’ Padcev (enfortumab vedotin-ejfv) plus Merck’s Keytruda (pembrolizumab) as a perioperative treatment for adults with muscle-invasive bladder cancer who are ...

Editor's Note: This is an excerpt from WBUR's weekly health newsletter, CommonHealth. If you like what you read and want it in your inbox, sign up here. Bladder cancer hits men especially hard. The ...

Patients with muscle-invasive bladder cancer have varied outcomes after cystectomy. Circulating tumor DNA (ctDNA)–based detection of molecular residual disease may identify patients at high risk for ...

Trump's Pentagon name change could cost up to $2 billion Massive college football fight leads to suspensions for more than two dozen players A seismic shift in computing is on the horizon (and it’s ...

NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...